CARE.STCARE.STSTO
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +14.79% | -1.57% | -11.90% | +5.95% | +0.87% |
| Gross Profit Growth | +26.81% | +2.33% | -8.47% | +9.39% | -0.79% |
| EBITDA Growth | -2.67% | -1.72% | -28.12% | +7.60% | -33.56% |
| Operating Income Growth | +68.79% | -13.09% | -54.13% | -13.13% | -68.68% |
| Net Income Growth | +228.79% | -47.41% | -56.82% | -23.00% | -44.70% |
| EPS Growth | +229.63% | -48.21% | -57.41% | -21.95% | -44.94% |
| EPS Diluted Growth | +229.63% | -48.21% | -57.41% | -21.95% | -44.94% |
| Weighted Average Shares Growth | +0.00% | +0.00% | -0.48% | +0.00% | +0.00% |
| Weighted Average Shares Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -34.76% | -33.22% | +44.29% | +154.41% | +97.72% |
| Free Cash Flow Growth | -71.70% | -79.52% | +100.00% | +560.61% | +144.85% |
| Receivables Growth | +41.11% | +17.31% | -11.41% | +18.63% | -9.75% |
| Inventory Growth | +17.84% | +12.85% | -35.16% | -17.75% | +1.83% |
| Asset Growth | +9.17% | +1.53% | -0.90% | +2.15% | +3.74% |
| Book Value per Share Growth | +24.78% | +4.89% | +6.19% | +4.47% | +0.49% |
| Debt Growth | -30.04% | -3.85% | -1.26% | +2.17% | +6.55% |
| R&D Expense Growth | +78.72% | +90.48% | +42.86% | +18.52% | +41.67% |
| SG&A Expenses Growth | +12.71% | +1.19% | -1.44% | +13.99% | +16.47% |